These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34370689)

  • 1. [Retrospective analysis of chronic myeloid leukemia patients treated in the Department of Internal Medicine and Oncology, Semmelweis University, between 2003 and 2019].
    Weisinger J; Tárkányi I; Hanna E; Kárpáti Á; Nagy Z; Timár B; Csomor J; Kiss R; Gángó A; Bödör C; Demeter J
    Orv Hetil; 2021 Aug; 162(32):1297-1302. PubMed ID: 34370689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-time progression-free survival in relapsed, refractory multiple myeloma with the oral ixazomib-lenalidomide-dexamethasone regime].
    Hardi A; Varga G; Nagy Z; Kosztolányi S; Váróczy L; Plander M; Schneider T; Demeter J; Alizadeh H; Illés Á; Masszi T; Mikala G
    Orv Hetil; 2021 Sep; 162(36):1451-1458. PubMed ID: 34482291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Practical management of side effects of tyrosine kinase inhibitor therapy in chronic myeloid leukemia].
    Mezei G; Illés Á; Batár P
    Orv Hetil; 2021 Jul; 162(30):1198-1207. PubMed ID: 34304154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short- and long-term prognostic significance of previous recanalization interventions in patients treated for myocardial infarction].
    Jánosi A; Ferenci T; Komócsi A; Andréka P
    Orv Hetil; 2021 Jan; 162(5):177-184. PubMed ID: 33517331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia].
    Fehér Á; Istenes I; Weisinger J; Király P; Rakonczai A; Tárkányi I; Kárpáti Á; Hanna E; Megyeri A; Nagy Z; Demeter J; Becker D
    Orv Hetil; 2021 Aug; 162(33):1335-1340. PubMed ID: 34392238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of patients treated for myocardial infarction in different regions of Hungary and patient survival for 10 years].
    Jánosi A; Pach FP; Erdős G; Tóth K; Hári P; Ofner P; Andréka P
    Orv Hetil; 2021 Sep; 162(36):1438-1450. PubMed ID: 34482289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Catheter-directed thrombolysis in acute critical limb ischemia].
    Zatykó DZ; Pomozi E; Pataki Á; Szeberin Z
    Orv Hetil; 2022 Mar; 163(11):424-430. PubMed ID: 35279648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Our experience with cytoreductive radical prostatectomy in patients with oligometastatic prostate cancer].
    Berczi C; Dócs J; Flaskó T
    Orv Hetil; 2021 Mar; 162(13):483-487. PubMed ID: 33774598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term analysis of the results of aorto-bifemoral bypass surgery for diffuse aorto-biiliac occlusive disease].
    Pomozi E; Lengyel B; Osztrogonácz P; Nguyen DT; Szeberin Z
    Orv Hetil; 2021 Jan; 162(3):99-105. PubMed ID: 33459610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical complications after kidney transplantation based on the Clavien classification, especially with regard to the types of ureteral anastomoses].
    Illésy L; Fedor R; Kovács DÁ; Kanyári Z; Zádori G; Szőllősi GJ; Kovács M; Flaskó T; Tóth J; Veisz R; Belán I; Nemes B
    Orv Hetil; 2021 Jun; 162(26):1038-1051. PubMed ID: 34175833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Decision-making and duration to accept device-aided therapy in advanced Parkinson’s disease].
    Szász JA; Szatmári S; Constantin V; Mihály I; Rácz A; Frigy A; Nagy E; Kelemen K; Forró T; Almásy E; Orbán-Kis K
    Orv Hetil; 2021 May; 162(21):839-847. PubMed ID: 34023813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ophthalmic use of TNFα inhibitor: adalimumab treatment in uveitis].
    Géhl Z; Szepessy Z; Nagy ZZ
    Orv Hetil; 2021 Aug; 162(34):1370-1375. PubMed ID: 34428173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Age and gender characteristics of patients affected with multiple sclerosis in Hungary between 2004 and 2016].
    Iljicsov A; Bereczki D; Dobi B; Oberfrank F; Bálint M; Ajtay A; Milanovich D; Simó M
    Orv Hetil; 2021 May; 162(19):746-753. PubMed ID: 33965907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of data from the National Vascular Registry on infrarenal aortic aneurysms (2010–2019)].
    Hidi L; Pál D; Boros AM; Kováts T; Menyhei G; Szeberin Z
    Orv Hetil; 2021 Aug; 162(31):1233-1243. PubMed ID: 34333458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical management of colonic diverticulosis: Issues of indications, treatment options, surgical solutions].
    György A; Barok B; Lukovich P
    Orv Hetil; 2020 Dec; 161(51):2146-2152. PubMed ID: 33346743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Graft survival using cadaver and multiorgan donors between 2008 and 2017 in our department].
    Kovács K; Szentmáry N; Pluzsik MT; Langenbucher A; Kiss H; Füst Á; Kriskó D; Rácz G; Matolcsy A; Nagy ZZ
    Orv Hetil; 2021 Mar; 162(13):488-496. PubMed ID: 33774599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Supplementary valproate therapy for glioma patients: An alternative opportunity to enhance the efficiency of radio-chemotherapy].
    Mezei T; Mészáros D; Pollner P; Bagó A; Fedorcsák I; Banczerowski P; Sipos L
    Orv Hetil; 2021 Jun; 162(24):960-967. PubMed ID: 34120100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of liver transplant waiting list in Hungary between 1995 and 2019].
    Görög D; Gerlei Z; Schuller J; Dezsőfi A; Hartmann E; Piros L; Sandil A; Szabó J; Fehérvári I; Fazakas J; Doros A; Kóbori L
    Orv Hetil; 2022 Feb; 163(8):301-311. PubMed ID: 35184050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of antibiotics in suspected early-onset neonatal sepsis].
    Mari J; Kajlik R; Gajda A; Kiss J; Gyurkovits Z
    Orv Hetil; 2022 Mar; 163(11):431-437. PubMed ID: 35279649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term follow-up of inflammatory bowel disease patients receiving anti-tumor necrosis factor-alpha therapy].
    Bacsur P; Skribanek S; Milassin Á; Farkas K; Bor R; Fábián A; Rutka M; Bálint A; Szántó KJ; Tóth T; Nagy F; Szepes Z; Boda K; Molnár T
    Orv Hetil; 2020 Nov; 161(47):1989-1994. PubMed ID: 33226355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.